Technetium-99m sestamibi imaging in the detection of axillary lymph node involvement in patients with breast cancer

Anticancer Research

Volumn 17, Issue 3 B, 1997, Pages 1607-1610

  Schillaci, Orazio ^a,b   Scopinaro, Francesco ^a   Danieli, Roberta ^a   Tavolaro, Rosanna ^a   Cannas, Pina ^a   Picardi, Valentina ^a   Colella, Antonio Centi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Axillary lymph nodes; Breast cancer; Technetium 99m sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SCINTIGRAPHY; TOMOGRAPHY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030945837     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Shek LLM, Godolphin W: Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. Cancer Res 48: 5565-5569, 1988.
2. Donegan WL: Prognostic factors. Stage and receptor status in breast camcer. Cancer 70: 1755-1764, 1992.
3. Allan SM: The prospects for imaging lymph nodes in breast cancer. Eur J Nucl Med 19: 836-837, 1992.
4. Lam WWM, Yang WT, Chan YL, et al: Detection of axillary lymph node metastases in breast carcinoma by technetium-99m sestamibi breast scintigraphy, ultrasound and conventional mammograpny. Eur J Nucl Med 23: 498-503, 1996.
5. Miller BA, Feuer EJ, Hankey BF: Recent incidence trends of breast cancer in women and the relevance of early detection: an update. CA 43: 27-41, 1993.
6. Pamilo M, Soiva M, Lavast EM: Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med 8: 115-120, 1989.
7. March DE, Wechsler RJ, Kurtz AB, et al: CT-pathologic correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr 15: 440-444, 1991.
8. de Freitas R Jr, Costa MV, Schneider SV, et al: Accuracy of iltrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 17: 240-244, 1991.
9. Mustonen P, Farin P, Kosunen O: Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. Ann Chir Gynaecol 79: 15-18, 1990.
10. Tate JJ, Lewis V, Archer T, et al: Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 15: 139-141, 1989.
11. Bruneton JN, Caramella E, Hery M, et al: Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 158: 325-326, 1986.
12. Walsh JS, Dixon JM, Chetty U, et al: Colour doppler studies of axillary node metastases in breast carcinoma. Clin Rad 49: 189-191, 1994.
13. Yang WT, Ahuja A, Tang A, et al: Haigh resolution monographic detection of axillary lymph node metastases. J Ultrasound Med 16: 241-246, 1996.
14. 99mTc-SestaMIBI in oncology. Tumori 82: 12-21, 1996.
15. Scopinaro F, Schillaci O, Scarpini M et al: Technetium-99m sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 21: 984-987, 1994.
16. Khalkhali I, Cutrone JA, Mena IG et al: Scimimammography: the complimentary role of Tc-99m sestamibi prone breast imaging for the diagnosis of brest cancer. Radiology 196: 421-426, 1996.
17. Taillefer R, Robidoux A, Lambert R et al: Technetium-99m-sestamibi prone scmtimammography to detect primary breast: cancer and axillary lymph node involvement. J Nucl Med 36: 1758-1765, 1995.
18. Palmedo H, Schomburg A, Grunwald F et al: Technetium-99m-MIBI scintimammography for suspicious breast lesions. J Nucl Med 37: 626-630, 1996.
19. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24, 740 breast cancer cases. Cancer 63: 181-187, 1989.
20. Nemoto T, Vans J, Bedwani RN, et al: Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45: 2917-2924, 1980.
21. Lamki LM, Buzdar AU, Singletary SE, et al: Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study. J Nucl Med 32: 1326-1332, 1991.
22. Tjandra JJ, Sacks NP, Thompson CH, et al: The detection of axillary lymph node metastases from breast cancer by radioabelled monoclonal antibodies: a prospective studies. Br J Cancer 52: 296-302, 1989.
23. Tjandra JJ, Russel IS, Collins JP, et al: Immunolymphoscintigraphy for the detection of axillary lymph node metastases from breast cancer. Cancer Res 49: 1600-1608, 1989.
24. Hoh CK, Hawkins RA, Glapy J, et al: Cancer detection with whole-body PET using 2-[F-18]-fluoro-2-deoxy-D-glucose. J Comput Assist Tomogr 17: 582-589, 1993.
25. Adler L, Crowe J, Al-Kaisi NK, et al: Evaluation of breast masses and axillary lymph nodes with 2-[F-18].deoxy-2-fluoro-D-glucose PET. Radiology 187: 743-750, 1993.
26. Nieweg OE, Kim EE, Wong WH, et al: Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer 71: 3920-3925, 1993.
27. Delmon-Mongeon LI, Piwinica-Worms D, Van der Abbeele AD et al: Uptake of the cation hexakis (2-methoxyisobutilisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 50: 2198-2202, 1990.
28. Maublant J, de Latour M, Mestas D et al: Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. J Nucl Med 37. 922-925, 1996.
29. Nagaraj N, Waxman A, Ashok G et al: Comparison of SPECT and planar Tc-99m sestaMIBI imaging in patients with carcinoma of the breast. J Nucl Med 35: 222P, 1994.